Scanvion, Quentin <br/><br/>
Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database.  [electronic resource] 

 -  Oncoimmunology  2020 
 - 1722022 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>2162-4011 
<br/><br/><label>Standard No.: </label>10.1080/2162402X.2020.1722022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Immunological<br/>Databases, Factual<br/>Humans<br/>Hypereosinophilic Syndrome--chemically induced<br/>Immune Checkpoint Inhibitors<br/>Pharmacovigilance